Is serum biotinidase enzyme activity a potential marker of perturbed glucose and lipid metabolism?

GSD IV GSD Ia biotinidase fatty acid synthesis gluconeogenesis glycogen storage disease

Journal

JIMD reports
ISSN: 2192-8304
Titre abrégé: JIMD Rep
Pays: United States
ID NLM: 101568557

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 17 04 2020
revised: 26 08 2020
accepted: 31 08 2020
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 22 1 2021
Statut: epublish

Résumé

Glycogen storage diseases (GSDs) belong to the group of inborn errors of carbohydrate metabolism. Hepatic GSDs predominantly involve the liver and most present with hepatomegaly. Biochemically they show known disturbances in glucose and fatty acids metabolism, namely fasting hypoglycaemia and increased triglycerides. Additionally, increased biotinidase (BTD) enzyme activity has been shown to be associated with many GSD types, whereas the mechanism by which BTD enzyme activity is altered remains unknown so far. We aimed to delineate changes in gluconeogenesis and fatty acid synthesis, potentially explaining raised BTD enzyme activity, by using liver (specimens from 2 patients) and serum samples of GSD Ia and GSD IV patients. By expression analysis of genes involved in gluconeogenesis, we ascertained increased levels of phosphoenolpyruvate carboxykinase and fructose-1,6-biphosphatase, indicating an increased flux through the gluconeogenic pathway. Additionally, we found increased gene expression of the biotin-dependent pyruvate and acetyl-CoA carboxylases, providing substrate for gluconeogenesis and increased fatty acid synthesis. We also observed a significant linear correlation between BTD enzyme activity and triglyceride levels in a cohort of GSD Ia patients. The results of this pilot study suggest that enhancement of BTD activity might serve the purpose of providing extra cofactor to the carboxylase enzymes as an adjustment to disturbed glucose and fatty acid metabolism. Future studies involving a higher number of samples should aim at confirming the here proposed mechanism, which extends the application of BTD enzyme activity measurement beyond its diagnostic purpose in suspected GSD, and opens up possibilities for its use as a sensor for increased gluconeogenesis and fatty acid synthesis.

Identifiants

pubmed: 33473341
doi: 10.1002/jmd2.12168
pii: JMD212168
pmc: PMC7802622
doi:

Types de publication

Journal Article

Langues

eng

Pagination

58-66

Informations de copyright

© 2020 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM.

Déclaration de conflit d'intérêts

P Forny has no conflicts of interests to declare. P Burda has no conflicts of interests to declare. P Bode has no conflicts of interests to declare. M Rohrbach has no conflicts of interests to declare.

Références

J Clin Endocrinol Metab. 2004 Sep;89(9):4656-64
pubmed: 15356077
J Biol Chem. 2001 Jul 13;276(28):25727-35
pubmed: 11346646
Neurology. 2004 Sep 28;63(6):1053-8
pubmed: 15452297
Genet Med. 2014 Nov;16(11):e1
pubmed: 25356975
J Endocrinol. 2018 Sep;238(3):R131-R141
pubmed: 29875163
J Int Soc Sports Nutr. 2004 Dec 31;1(2):7-11
pubmed: 18500949
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):e52-e54
pubmed: 25304890
J Biol Chem. 2009 Sep 25;284(39):26578-90
pubmed: 19635791
J Inherit Metab Dis. 2015 May;38(3):537-43
pubmed: 25633903
Pediatr Res. 2008 Jun;63(6):702-7
pubmed: 18520334
J Pediatr. 1988 Jan;112(1):55-8
pubmed: 3422093
Biochem J. 2008 Aug 1;413(3):369-87
pubmed: 18613815
Hum Pathol. 2012 Jun;43(6):943-51
pubmed: 22305237
J Biol Chem. 2002 Aug 23;277(34):30409-12
pubmed: 12087111
J Inherit Metab Dis. 2007 Nov;30(6):896-902
pubmed: 17994282
Eur J Biochem. 1969 Sep;10(2):351-4
pubmed: 4309869
Diabetes. 2001 Nov;50(11):2591-7
pubmed: 11679439
Biochim Biophys Acta. 2014 Apr;1840(4):1313-30
pubmed: 24177027
Hum Mol Genet. 2015 Oct 15;24(20):5667-76
pubmed: 26199317

Auteurs

Patrick Forny (P)

Division of Metabolism and Children's Research Center University Children's Hospital Zurich Zurich Switzerland.

Patricie Burda (P)

Division of Metabolism and Children's Research Center University Children's Hospital Zurich Zurich Switzerland.

Peter Bode (P)

Institute of Surgical Pathology University Hospital Zurich Zurich Switzerland.

Marianne Rohrbach (M)

Division of Metabolism and Children's Research Center University Children's Hospital Zurich Zurich Switzerland.

Classifications MeSH